AstraZeneca PLC (AZN)
166.08
-0.06
(-0.04%)
USD |
NYSE |
Sep 18, 16:00
166.29
+0.21
(+0.13%)
After-Hours: 20:00
AstraZeneca Total Return Level : 419.21 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 419.21 |
| September 17, 2026 | 419.36 |
| September 16, 2026 | 411.16 |
| September 15, 2026 | 408.53 |
| September 14, 2026 | 413.40 |
| September 11, 2026 | 404.29 |
| September 10, 2026 | 402.95 |
| September 09, 2026 | 396.14 |
| September 08, 2026 | 403.96 |
| September 04, 2026 | 410.68 |
| September 03, 2026 | 415.90 |
| September 02, 2026 | 407.98 |
| September 01, 2026 | 410.10 |
| August 31, 2026 | 409.24 |
| August 28, 2026 | 410.68 |
| August 27, 2026 | 415.27 |
| August 26, 2026 | 419.69 |
| August 25, 2026 | 428.24 |
| August 24, 2026 | 420.80 |
| August 21, 2026 | 418.96 |
| August 20, 2026 | 415.19 |
| August 19, 2026 | 416.36 |
| August 18, 2026 | 404.11 |
| August 17, 2026 | 396.01 |
| August 14, 2026 | 394.90 |
| Date | Value |
|---|---|
| August 13, 2026 | 396.89 |
| August 12, 2026 | 400.08 |
| August 11, 2026 | 400.71 |
| August 10, 2026 | 408.68 |
| August 07, 2026 | 407.45 |
| August 06, 2026 | 403.88 |
| August 05, 2026 | 404.96 |
| August 04, 2026 | 390.22 |
| August 03, 2026 | 396.11 |
| July 31, 2026 | 425.37 |
| July 30, 2026 | 429.63 |
| July 29, 2026 | 434.55 |
| July 28, 2026 | 432.49 |
| July 27, 2026 | 425.37 |
| July 24, 2026 | 424.42 |
| July 23, 2026 | 421.94 |
| July 22, 2026 | 425.60 |
| July 21, 2026 | 424.62 |
| July 20, 2026 | 412.53 |
| July 17, 2026 | 423.52 |
| July 16, 2026 | 424.49 |
| July 15, 2026 | 422.19 |
| July 14, 2026 | 412.48 |
| July 13, 2026 | 424.95 |
| July 10, 2026 | 430.31 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| GSK Plc | 191.51 |
| Johnson & Johnson | 644.25 |
| Eli Lilly & Co. | 3046.28 |
| Merck & Co., Inc. | 454.18 |
| Novo Nordisk A/S | 77.38 |